Clinical Trials
Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite
Phesi, a data-driven provider of clinical development analytics products and solutions, announced a new country selection functionality has been added to ClinSite, its platform to...
News
Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service
Okapi Pharmacy, a wholly-owned subsidiary of Toppan Printing, a global leader in communication, security, packaging, décor materials, and electronics solutions, has announced the launch of...
News
YoSync Collaborates with IIIT Bangalore to Launch India’s First-Ever COVID-19 Blockchain Platform, BelYo
YoSync, a startup incubated at IIITB-IMACX Studios, signed a research collaboration in agreement with IIIT Bangalore, to partner with BelfricsBT, a Malaysian based blockchain startup....
News
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial...
News
Sharp acquires stake in Berkshire Sterile Manufacturing
Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased a minority ownership in Berkshire Sterile Manufacturing...
News
DHL Global forwarding supports Kuwait’s fight against Covid-19
DHL’s global network and expertise in handling humanitarian logistics provide uninterrupted supply of essential COVID-19 medical supplies to Kuwait’s frontline health workers
Over the course of...
News
Lupin Launches Favipiravir Drug Covihalt for Treatment of Mild to Moderate COVID-19
Pharma major Lupin Limited (Lupin) announced the launch of its Favipiravir in India under the brand name Covihalt® for the treatment of mild to moderate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.